Korro Bio's OPERA platform offers precise RNA editing for genetic diseases like Alpha-1 antitrypsin deficiency. Learn more on ...

ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Jumpcode Genomics ('Jumpcode'), a life science tools company improving and reducing the cost of next-generation sequencing technology, ...

The global CAR T-cell therapy market is projected to grow from USD 2.7 billion in 2025 to over USD 27.5 billion by 2033, reflecting a robust CAGR of 26.2%.

Turn Biotechnologies, a pioneer in epigenetic reprogramming, announced the acquisition of groundbreaking ARMMs (ARRDC1 Mediated Microvesicles) technology to broadly expand the number of organs, ...

In this interview, News Medical speaks with Olivier Negre, Chief Scientific Officer at Smart Immune, about how immunotherapy ...

In the last year, some drugmakers have pulled back from the sector, including Pfizer, which recently stopped selling its gene ...

Biohacking combines science and lifestyle changes, offering strategies like intermittent fasting and sleep optimization to ...

“This financing is a testament to the hard work of our team as well as our consistent focus and capital-efficient execution in developing a differentiated portfolio of gene editing therapeutics with ...

Discover 7 key signs that indicate it's time to refresh or change your company logo design for better branding and business growth this year. $3.2 million. That's what the average logo redesign costs ...

Mary Beard, one of Britain’s best-known classicists and the author of many acclaimed books on ancient Rome, gives this year’s Leon Levy Lecture on the craft of biography. Her most recent book, Emperor ...

ElevateBio will leverage artificial intelligence to expand and accelerate CRISPR discovery, design, and drug development for thousands of complex ...

BEAM-302 showed durable, dose-dependent correction of AATD mutation in 9 patients with effects seen as early as Day 7. Beam plans further dose escalation and will report new trial data in H2 2025 ...